According to Yield10 Bioscience's latest financial reports the company has S$0.98 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | S$5.82 M | -73.04% |
2021-12-31 | S$21.61 M | 68.42% |
2020-12-31 | S$12.83 M | -14.36% |
2019-12-31 | S$14.98 M | 90.17% |
2018-12-31 | S$7.88 M | -59.33% |
2017-12-31 | S$19.37 M | 83.17% |
2016-12-31 | S$10.57 M | -39.05% |
2015-12-31 | S$17.35 M | -34.48% |
2014-12-31 | S$26.48 M | 8.83% |
2013-12-31 | S$24.33 M | -54.53% |
2012-12-31 | S$53.53 M | -46.22% |
2011-12-31 | S$99.53 M | 25.49% |
2010-12-31 | S$79.31 M | -38.73% |
2009-12-31 | S$0.12 B | -0.64% |
2008-12-31 | S$0.13 B | -17.19% |
2007-12-31 | S$0.15 B | -15.96% |
2006-12-31 | S$0.18 B | 3442.25% |
2005-12-31 | S$5.28 M | -27.28% |
2004-12-31 | S$7.26 M |